MILLER CONVERT TOT RET ETF (MCVT) Fundamental Analysis & Valuation

Q: Can you provide the ChartMill fundamental rating for MILLER CONVERT TOT RET ETF?

ChartMill assigns a fundamental rating of 5 / 10 to MCVT.

NYSEARCA:MCVT • US60055P8216

26.25 USD

+0.25 (+0.96%)

Last: Apr 30, 2026, 12:36 PM

This MCVT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1. MCVT Profitability Analysis

1.1 Basic Checks

MCVT had positive earnings in the past year.
MCVT had a negative operating cash flow in the past year.
MCVT had positive earnings in 4 of the past 5 years.
MCVT had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 7.34%, MCVT belongs to the top of the industry, outperforming 86.00% of the companies in the same industry.
MCVT has a Return On Equity of 7.41%. This is comparable to the rest of the industry: MCVT outperforms 44.00% of its industry peers.
MCVT's Return On Invested Capital of 5.04% is fine compared to the rest of the industry. MCVT outperforms 68.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	7.34%
ROE	7.41%
ROIC	5.04%

ROA(3y)0.06%

ROA(5y)6.96%

ROE(3y)0.09%

ROE(5y)8.07%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MCVT has a better Profit Margin (45.42%) than 88.00% of its industry peers.
In the last couple of years the Profit Margin of MCVT has declined.
MCVT has a better Operating Margin (42.15%) than 82.00% of its industry peers.
MCVT's Operating Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	42.15%
PM (TTM)	45.42%
GM	N/A

OM growth 3Y-6.34%

OM growth 5YN/A

PM growth 3Y-30.72%

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA ROE ROIC Operating and Profit Margin Show most profitable peers

2. MCVT Health Analysis

2.1 Basic Checks

Compared to 1 year ago, MCVT has about the same amount of shares outstanding.
MCVT has more shares outstanding than it did 5 years ago.
MCVT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MCVT has an Altman-Z score of 6703.60. This indicates that MCVT is financially healthy and has little risk of bankruptcy at the moment.
MCVT has a Altman-Z score of 6703.60. This is amongst the best in the industry. MCVT outperforms 100.00% of its industry peers.
There is no outstanding debt for MCVT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	6703.6

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 10.21 indicates that MCVT has no problem at all paying its short term obligations.
MCVT has a Current ratio of 10.21. This is amongst the best in the industry. MCVT outperforms 100.00% of its industry peers.
A Quick Ratio of 10.21 indicates that MCVT has no problem at all paying its short term obligations.
The Quick ratio of MCVT (10.21) is better than 100.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	10.21
Quick Ratio	10.21

More info and screens

WACC Debt/Equity How to determine the health of a company Altman-Z score Show peers with great health

3. MCVT Growth Analysis

3.1 Past

MCVT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 478.74%, which is quite impressive.
MCVT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -48.38% yearly.
MCVT shows a small growth in Revenue. In the last year, the Revenue has grown by 1.76%.
MCVT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 83.19% yearly.

EPS 1Y (TTM)478.74%

EPS 3Y-48.38%

EPS 5YN/A

EPS Q2Q%75.91%

Revenue 1Y (TTM)1.76%

Revenue growth 3Y7.46%

Revenue growth 5Y83.19%

Sales Q2Q%6.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks Show best growing peers

4. MCVT Valuation Analysis

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 109.38 indicates a quite expensive valuation of MCVT.
MCVT's Price/Earnings ratio is a bit more expensive when compared to the industry. MCVT is more expensive than 77.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.54, MCVT is valued quite expensively.

		Industry Rank	Sector Rank
PE	109.38
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Price/Earnings Price/FCF FCF per share EV/EBITDA PEG RATIO Show best valued peers

5. MCVT Dividend Analysis

5.1 Amount

No dividends for MCVT!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks Show peers with best dividend

MCVT Fundamentals: All Metrics, Ratios and Statistics

MILLER CONVERT TOT RET ETF

NYSEARCA:MCVT (4/30/2026, 12:36:34 PM)

26.25

+0.25 (+0.96%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryFinancial Services

Industry Strength97.52

Industry Growth49.07

Earnings (Last)08-14 2025-08-14

Earnings (Next)11-10 2025-11-10

Inst OwnersN/A

Inst Owner Change0%

Ins OwnersN/A

Ins Owner Change0%

Market Cap2.16B

Revenue(TTM)3.31M

Net Income(TTM)1.50M

AnalystsN/A

Price TargetN/A

Short Float %0.01%

Short Ratio0

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	109.38
Fwd PE	N/A
P/S	652
P/FCF	N/A
P/OCF	N/A
P/B	106.41
P/tB	106.41
EV/EBITDA	N/A

EPS(TTM)0.24

EY0.91%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.04

FCFYN/A

OCF(TTM)-0.04

OCFYN/A

SpS0.04

BVpS0.25

TBVpS0.25

PEG (NY)N/A

PEG (5Y)N/A

Graham Number1.15419 (-95.6%)

Profitability

		Industry Rank	Sector Rank
ROA	7.34%
ROE	7.41%
ROCE	6.88%
ROIC	5.04%
ROICexc	5.44%
ROICexgc	5.44%
OM	42.15%
PM (TTM)	45.42%
GM	N/A
FCFM	N/A

ROA(3y)0.06%

ROA(5y)6.96%

ROE(3y)0.09%

ROE(5y)8.07%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3Y-5.38%

ROICexgc growth 5YN/A

ROICexc growth 3Y-5.38%

ROICexc growth 5YN/A

OM growth 3Y-6.34%

OM growth 5YN/A

PM growth 3Y-30.72%

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.16

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	10.21
Quick Ratio	10.21
Altman-Z	6703.6

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)478.74%

EPS 3Y-48.38%

EPS 5YN/A

EPS Q2Q%75.91%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)1.76%

Revenue growth 3Y7.46%

Revenue growth 5Y83.19%

Sales Q2Q%6.68%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y13.02%

EBIT growth 3Y0.65%

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-119.81%

FCF growth 3YN/A

FCF growth 5Y-5.88%

OCF growth 1Y-119.81%

OCF growth 3YN/A

OCF growth 5Y-5.88%

MILLER CONVERT TOT RET ETF / MCVT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MILLER CONVERT TOT RET ETF?

ChartMill assigns a fundamental rating of 5 / 10 to MCVT.

Can you provide the valuation status for MILLER CONVERT TOT RET ETF?

ChartMill assigns a valuation rating of 0 / 10 to MILLER CONVERT TOT RET ETF (MCVT). This can be considered as Overvalued.

How profitable is MILLER CONVERT TOT RET ETF (MCVT) stock?

MILLER CONVERT TOT RET ETF (MCVT) has a profitability rating of 4 / 10.

Can you provide the PE and PB ratios for MCVT stock?

The Price/Earnings (PE) ratio for MILLER CONVERT TOT RET ETF (MCVT) is 109.38 and the Price/Book (PB) ratio is 106.41.